Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Phreesia, Inc. Common Stock (NY:PHR)

23.00 -0.84 (-3.53%)
Streaming Delayed Price Updated: 1:31 PM EDT, Oct 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Phreesia, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Phreesia Announces First Quarter Fiscal 2026 Results
From Phreesia, Inc.
Via Business Wire
Earnings Scheduled For May 28, 2025
 
Via Benzinga
What to Expect from Phreesia's Earnings
 
Via Benzinga
Breaking Down Phreesia: 9 Analysts Share Their Views
 
Via Benzinga
Deep Dive Into Phreesia Stock: Analyst Perspectives (5 Ratings)
 
Via Benzinga
Phreesia (PHR) Reports Q1: Everything You Need To Know Ahead Of Earnings
Healthcare technology company Phreesia (NYSE:PHR) will be reporting results tomorrow after market hours. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
3 of Wall Street’s Favorite Stocks Skating on Thin Ice
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
Phreesia Updates May 28, 2025, Earnings Release Information for Fiscal First Quarter 2026 Results
From Phreesia, Inc.
Via Business Wire
1 Cash-Heavy Stock with Impressive Fundamentals and 2 to Ignore
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits,... 
Via StockStory
Phreesia Sets Release Date for Fiscal First Quarter 2026 Results
From Phreesia, Inc.
Via Business Wire
Winners And Losers Of Q4: Evolent Health (NYSE:EVH) Vs The Rest Of The Healthcare Technology for Providers Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Evolent Health (NYSE:EVH) and... 
Via StockStory
Unpacking Q4 Earnings: Omnicell (NASDAQ:OMCL) In The Context Of Other Healthcare Technology for Providers Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Omnicell (NASDAQ:OMCL) and the best and... 
Via StockStory
Q4 Earnings Highs And Lows: Premier (NASDAQ:PINC) Vs The Rest Of The Healthcare Technology for Providers Stocks
Looking back on healthcare technology for providers stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Premier (NASDAQ:PINC) and its peers. 
Via StockStory
Topics Economy
Healthcare Technology Stocks Q4 In Review: Hims & Hers Health (NYSE:HIMS) Vs Peers
Let’s dig into the relative performance of Hims & Hers Health (NYSE:HIMS) and its peers as we unravel the now-completed Q4 healthcare technology earnings season. 
Via StockStory
Q4 Rundown: Astrana Health (NASDAQ:ASTH) Vs Other Healthcare Technology for Providers Stocks
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Astrana Health (NASDAQ:ASTH) and its peers. 
Via StockStory
Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks
Let’s dig into the relative performance of Tandem Diabetes (NASDAQ:TNDM) and its peers as we unravel the now-completed Q4 healthcare technology earnings season. 
Via StockStory
4 Analysts Have This To Say About Phreesia
 
Via Benzinga
Select Medical, Phreesia, Eli Lilly, Pfizer, and Brink's Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White House clarified the tariffs on imports from China would add up to 145%,... 
Via StockStory
Topics Economy Government World Trade
1 Healthcare Stock with Exciting Potential and 2 to Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory... 
Via StockStory
Topics Stocks
1 Small-Cap Stock with Solid Fundamentals and 2 to Ignore
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
Topics Supply Chain
Q4 Earnings Review: Healthcare Technology for Providers Stocks Led by Phreesia (NYSE:PHR)
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Phreesia (NYSE:PHR) and its peers. 
Via StockStory
Phreesia Named to G2’s List of 2025 Best Healthcare Software Products
From Phreesia, Inc.
Via Business Wire
6 Analysts Have This To Say About Phreesia
 
Via Benzinga
Phreesia (NYSE:PHR) Posts Better-Than-Expected Sales In Q4 But Stock Drops
Healthcare technology company Phreesia (NYSE:PHR) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 15.4% year on year to $109.7 million. The company expects the full year’s revenue... 
Via StockStory
Phreesia Announces Fourth Quarter Fiscal 2025 Results
From Phreesia, Inc.
Via Business Wire
Earnings Scheduled For March 12, 2025
 
Via Benzinga
Phreesia (PHR) To Report Earnings Tomorrow: Here Is What To Expect
Healthcare technology company Phreesia (NYSE:PHR) will be reporting results tomorrow after the bell. Here’s what to look for. 
Via StockStory
Phreesia’s Sally Thayer Selected as a Top Woman Leader in Software
From Phreesia, Inc.
Via Business Wire
Phreesia Sets Release Date for Fiscal Fourth Quarter and Fiscal Year 2025 Results
From Phreesia, Inc.
Via Business Wire
Here's Why Phreesia's Average Revenue Per Client Will Accelerate: Analyst
Analyst predicts Phreesia's revenue per client will accelerate, as company shifts focus to monetizing existing clients. Upgraded rating and PT raised. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.